ACT Capital Partners, L.P.’s Tango Therapeutics TNGX Stock Holding History

ACT Capital Partners, L.P.’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$150K	Buy	+6,000	New	+$156K	0.1%	52

Other funds holding TNGX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Mass General Brigham Somerville, Massachusetts $456M AUM 27.51% 1-Year Est. Return

ACT Capital Partners, L.P.'s TNGX Position: Q3 2026 in Review

ACT Capital Partners, L.P. opened a new position in Tango Therapeutics (TNGX) in Q3 2026: 6,000 shares worth $150K. The stake represents 0.1% of the portfolio and ranks #52 among its holdings.

74 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

ACT Capital Partners, L.P. held 6,000 shares of Tango Therapeutics worth $150K as of Q3 2026.
Tango Therapeutics was a new ACT Capital Partners, L.P. position in Q3 2026.
Tango Therapeutics made up 0.1% of ACT Capital Partners, L.P.'s portfolio in Q3 2026, its #52 holding.
74 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on ACT Capital Partners, L.P.'s 13F filing for Q3 2026, filed 6 Nov 2026.